Cat. No. | Product Name / Activity |
---|---|
3400 | RuBi-GABA |
Caged GABA; excitable at visible wavelengths | |
3401 | Vinorelbine ditartrate |
Selective mitotic microtubule antagonist | |
3402 | Tubacin |
HDAC6 inhibitor; inhibits a-tubulin deacetylation | |
3404 | S 32826 |
Potent autotaxin inhibitor | |
3405 | COG 133 |
ApoE peptide fragment | |
3406 | GLYX 13 |
NMDA partial agonist; acts at the glycine site | |
3407 | R 715 |
Potent and selective B1 antagonist | |
3409 | BMS 453 |
Synthetic retinoid and RARβ agonist; also RARα and RARγ antagonist | |
3410 | BMS 961 |
Selective RARγ agonist | |
3411 | SR 11237 |
Pan RXR agonist | |
3412 | (Z)-4-Hydroxytamoxifen |
Metabolite of tamoxifen (Cat. No. 0999) | |
3413 | YM 202074 sesquifumarate |
High affinity, selective mGlu1 antagonist | |
3414 | FAK Inhibitor 14 |
Selective FAK inhibitor | |
3415 | DMPO |
Nitric oxide spin trap; measure oxygen-centered free radicals | |
3416 | Tris DBA |
N-myristoyltransferase-1 inhibitor; antiproliferative | |
3417 | CP 99994 dihydrochloride |
High affinity NK1 antagonist | |
3418 | Amylin |
Endogenous peptide agonist for amylin, calcitonin, CGRP and adrenomedullin receptors | |
3419 | AC 187 |
Potent and selective amylin antagonist | |
3420 | SHU 9119 |
MC3 and MC4 antagonist; MC5 partial agonist | |
3422 | [D-Phe12,Leu14]-Bombesin |
Bombesin receptor antagonist | |
3424 | γ1-MSH |
Selective MC3 receptor agonist | |
3425 | M40 |
Potent, non-selective galanin receptor antagonist | |
3426 | JKC 363 |
Potent and selective MC4 receptor antagonist | |
3427 | Oncrasin 1 |
Induces abnormal nuclear aggregation of PKCι; proapoptotic | |
3429 | 4-IPP |
Inhibitor of macrophage migration inhibitory factor (MIF); suicide substrate | |
3430 | CFTRinh 172 |
Voltage-independent, selective CFTR chloride channel blocker | |
3433 | GSK 0660 |
Selective PPARδ antagonist | |
3434 | [Ala17]-MCH |
Potent MCH receptor agonist | |
3435 | Insulin (human) recombinant expressed in yeast |
Endogenous peptide agonist | |
3436 | [D-Trp34]-Neuropeptide Y |
Potent NPY Y5 agonist; orexigenic | |
3438 | MCL 0020 |
Selective MC4 receptor antagonist | |
3439 | NH 125 |
CaM kinase III (eEF-2 kinase) inhibitor | |
3440 | SID 7969543 |
Selective steroidogenic factor-1 (SF-1, NR5A1) inhibitor | |
3489 | Astemizole |
Orally active, potent H1 antagonist; also KV11.1 (hERG) channel blocker | |
3490 | UCPH 101 |
Selective non-substrate EAAT1 inhibitor | |
3491 | Prion Protein 106-126 (human) |
Prion protein fragment | |
3492 | ACTH (1-39) |
Potent endogenous MC2 agonist | |
3493 | Cyclosomatostatin |
Non-selective sst antagonist | |
3495 | Fludarabine |
Purine analog; inhibits DNA synthesis | |
3496 | BX 471 |
Potent, selective CCR1 antagonist | |
3497 | TRAP-6 |
PAR1 peptide fragment (residues 42-47); acts as a PAR1 agonist | |
3498 | RGDS peptide |
Integrin binding sequence; inhibits integrin receptor function | |
3499 | ML 10302 hydrochloride |
Potent and selective 5-HT4 partial agonist |